REVELATION BIOSCIENCES, INC. Common Stock, Capital Shares Reserved for Future Issuance
REVELATION BIOSCIENCES, INC. (REVB) had Common Stock, Capital Shares Reserved for Future Issuance of 9.99 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-06
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 9.99M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 9.29M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 4.85M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 20.68M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 9.99M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 9.29M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 4.85M shares 10-K · filed 2026-02-26 | |
| 2025-09-30 | 20.68M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 1.70M shares 10-Q · filed 2026-08-06 | 6.80M shares 10-Q · filed 2025-08-08 |
| 2025-03-31 | 159.66K shares 10-Q · filed 2026-05-07 | 1.92M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 80.89K shares 10-K · filed 2026-02-26 | 970.61K shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 111.87K shares 10-Q · filed 2025-11-06 | 5.37M shares 10-Q · filed 2024-11-08 |
| 2024-06-30 | 60.89K shares 10-Q · filed 2025-08-08 | 2.92M shares 10-Q · filed 2024-08-09 |
| 2024-03-31 | 3.18K shares 10-Q · filed 2025-05-08 | 50.93K shares 10-Q · filed 2024-05-10 |
| 2023-12-31 | 3.71K shares 10-K · filed 2025-03-06 | 59.42K shares 10-K · filed 2024-03-22 |
| 2023-09-30 | 40.08K shares 10-Q · filed 2024-11-08 | 1.20M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 40.08K shares 10-Q/A · filed 2024-09-23 | 1.20M shares 10-Q · filed 2023-08-11 |
| 2023-03-31 | 163.29K shares 10-Q/A · filed 2024-09-23 | 4.90M shares 10-Q · filed 2023-05-22 |
| 2022-12-31 | 23.98K shares 10-K/A · filed 2024-09-23 | 719.66K shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 719.66K shares 10-Q · filed 2023-11-09 | 24.09M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 470.76K shares 10-Q · filed 2023-08-11 | 15.38M shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 470.76K shares 10-Q · filed 2023-05-22 | 15.38M shares 10-Q · filed 2022-05-16 |
| 2022-01-10 | 4.79K shares 10-K · filed 2023-03-30 | 167.87K shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 17.95K shares 10-K · filed 2023-03-30 | 167.87K shares 10-K · filed 2022-04-15 |
| 2021-09-30 | 4.21M shares 10-Q · filed 2022-11-10 | |
| 2021-06-30 | 4.21M shares 10-Q · filed 2022-08-15 | |
| 2021-03-31 | 4.21M shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |